The guidelines released in 2017 are going to serve as the foundation for molecular testing for all gastrointestinal (GI) cancers, says Antonia R. Sepulveda, MD, PhD.
http://www.onclive.com/web-exclusives/an-impactful-year-for-molecular-testing-in-gi-cancers
An Impactful Year for Molecular Testing in GI Cancers